We are an independent general interest entity dedicated since 1993 to the promotion and implementation of the Health Technology Assessment (HTA) in Spain.
Further define procedures to guarantee transparency associated with the entire evaluation process and the dissemination and implementation of decisions making on the basis of that evaluation.
Define a re-evaluation process with fixed deadlines to update technologies and their uses.
Consider the existence of thresholds of acceptability of availability to pay and
adapt them to certain pathologies such as cancer.
Promote the relevance of developing Health Technology Assessment Positioning Reports (PR-HTA) in line with EU recommendations.
Ensure that HTA determines, in an effective, coordinated and transparent way, the relative (clinical and economic) “value” of the new technology compared to current best clinical practice.
Guarantee that HTA reduces or eliminates the use of unsafe or ineffective technologies (disinvestment) through binding assessment of the highest scientific and technical quality.
We are committed to EUnetHTA and the Spanish Network of Agencies for the Assessment of Health Technology and Performance of the National Health System in the important work that they carry out in the homogenization and creation of standards of the evaluation reports and clinical practice guidelines that allow to give cohesion to the assessment of health technologies at national and European level.